Publicacións nas que colabora con Javier Fernandez Castroagudin (22)

2015

  1. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637

2014

  1. Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol

    Transplantation Proceedings

2013

  1. A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: A randomised controlled study

    Anaesthesia and Intensive Care, Vol. 41, Núm. 6, pp. 719-727

2012

  1. Late recurrence of hepatocellular carcinoma after liver transplantation: Is an active surveillance for recurrence needed?

    Transplantation Proceedings

2010

  1. Improvement of Renal Function After Conversion to Mycophenolate Mofetil Combined With Low-Level Calcineurin Inhibitor in Liver Transplant Recipients With Chronic Renal Dysfunction

    Transplantation Proceedings, Vol. 42, Núm. 2, pp. 656-659

2009

  1. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

    Liver Transplantation, Vol. 15, Núm. 12, pp. 1792-1797

  2. Safety of an Immunosuppressant Protocol Based on Sirolimus in Liver Transplant Recipients With Malignancies or High Risk of Tumor Recurrence

    Transplantation Proceedings, Vol. 41, Núm. 3, pp. 1003-1004

2008

  1. Orthotopic Liver Transplantation for Hepatocellular Carcinoma: A Thirteen-Year Single-Center Experience

    Transplantation Proceedings, Vol. 40, Núm. 9, pp. 2975-2977

2005

  1. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation

    Transplantation Proceedings

  2. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients

    Transplantation Proceedings

  3. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates

    Transplantation Proceedings

2004

  1. Hepatitis B virus genotyping based on cluster analysis of the region involved in lamivudine resistance

    Journal of Virological Methods, Vol. 115, Núm. 1, pp. 9-17

2003

  1. Utility of ambulatory blood pressure monitoring for diagnosis of hypertension in liver allograft recipients

    Transplantation Proceedings

2002

  1. Alternative immunosuppression for acute renal failure in liver transplantation: Role of ultra-low dose tacrolimus and basiliximab

    Transplantation Proceedings

  2. Bilateral adrenal metastases from hepatocellular carcinoma after liver transplantation

    Hepato-Gastroenterology, Vol. 49, Núm. 43, pp. 249-251

  3. Cardiovascular risk factors in liver allograft recipients: Relationship with immunosuppressive therapy

    Transplantation Proceedings

  4. Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus

    Transplantation Proceedings

2001

  1. Patología digestiva alta en pacientes de edad avanzada con anemia ferropénica: Comparación entre usuarios y no usuarios de anti-inflamatorios no esteroideos

    Anales de Medicina Interna, Vol. 18, Núm. 7, pp. 357-360

  2. Prevalence of liver disease in patients with Streptococcus bovis bacteraemia

    Journal of Infection, Vol. 42, Núm. 2, pp. 116-119

2000

  1. Intensive care during prolonged anhepatic state after total hepatectomy and porto-caval shunt (two-stage procedure) in surgical complications of liver transplantation

    Hepato-Gastroenterology, Vol. 47, Núm. 35, pp. 1343-1346